Elena Andreevna Krendeleva

Title: The Innovations of Elena Andreevna Krendeleva

Introduction

Elena Andreevna Krendeleva is a prominent inventor based in St. Petersburg, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has the potential to impact medical treatments and therapies.

Latest Patents

One of her latest patents is a monoclonal antibody that specifically binds to CD20. This invention relates to biotechnology and provides a monoclonal antibody that specifically binds to CD20. The invention also encompasses DNA encoding said antibody, the corresponding expression vectors, and methods of production thereof, as well as methods of treatment using said antibody. Another significant patent is the Anti-IL-5RAlpha monoclonal antibody. This disclosure relates to biotechnology and provides antibodies that specifically bind to IL-5Rα. It also includes DNA encoding the antibodies, the corresponding expression vectors, and methods of production thereof, along with methods of treatment using the antibodies.

Career Highlights

Elena is currently associated with Joint Stock Company "Biocad," where she continues to innovate and contribute to the field of biotechnology. Her work at Biocad has positioned her as a key player in the development of therapeutic solutions.

Collaborations

Elena collaborates with notable colleagues, including Pavel Andreevich Iakovlev and Mariia Aleksandrovna Shchemeleva. Their teamwork enhances the research and development efforts within their organization.

Conclusion

Elena Andreevna Krendeleva's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments.